Vertex initiates phase III studies of VX-445, tezacaftor and ivacaftor in cystic fibrosis April 27, 2018
FDA grants breakthrough therapy designation to OMS-721 for HSCT thrombotic microangiopathy April 27, 2018
New phase II trial studies ISA-101 with utomilumab for HPV16-positive oropharyngeal cancer April 27, 2018
Venglustat shows favorable safety and tolerability and biologic activity in healthy volunteers April 27, 2018
RSS